BCS Private Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74M Sell
4,800
-950
-17% -$325K 0.52% 49
2026
Q1
$2.02M Buy
5,750
+2,700
+89% +$963K 0.61% 43
2025
Q4
$998K Buy
3,050
+100
+3% +$31.7K 0.34% 61
2025
Q3
$832K Hold
2,950
0.3% 64
2025
Q2
$824K Buy
+2,950
New +$836K 0.31% 64

Other funds holding AMGN

BCS Private Wealth Management's AMGN Position: Q2 2026 in Review

BCS Private Wealth Management reduced its Amgen (AMGN) stake by 17% in Q2 2026, selling an estimated $325K and leaving 4,800 shares worth $1.74M. The position accounts for 0.52% of the portfolio, ranked #49.

BCS Private Wealth Management first reported a position in AMGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.02M in Q1 2026. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • BCS Private Wealth Management held 4,800 shares of Amgen worth $1.74M as of Q2 2026.
  • BCS Private Wealth Management sold 950 Amgen shares in Q2 2026, an estimated $325K.
  • Amgen made up 0.52% of BCS Private Wealth Management's portfolio in Q2 2026, its #49 holding.
  • BCS Private Wealth Management first reported a position in Amgen in Q2 2025 and has held it in 5 quarters since.
  • BCS Private Wealth Management's Amgen position peaked at $2.02M in Q1 2026.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on BCS Private Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.